Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ottawa Hospital Research Institute
With
Canadian Institutes of Health Research (CIHR)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals at least 18 years old
Individuals must be symptomatic with respiratory symptoms
Individuals must complete the UCAP-Q questionnaire and score a ≥ 6% probability of having either asthma or COPD.
Individuals who have given written informed consent to participate in this trial in accordance with local regulations;
Individual must be able to perform pre and post bronchodilator spirometry to measure lung function
Individuals who have undiagnosed airflow obstruction (i.e. Asthma will be diagnosed in subjects with airflow obstruction whose forced expiratory volume in 1 second (FEV1) improves by \> 12% and 200 ml after bronchodilator and COPD will be diagnosed in subjects who do not have a significant bronchodilator response and who exhibit persistent airflow obstruction post bronchodilator) will be asked to participate in the RCT.
You may not be if
Individuals who report a previous diagnosis of asthma, COPD, history of lung cancer, bronchiectasis, interstitial lung disease, cystic fibrosis or other significant diagnosed lung disease.
Individuals currently under the care of a respirologist
Individuals currently using inhaled corticosteroids or long-acting bronchodilators.
Individuals with history of myocardial infarction, stroke, aortic or cerebral aneurysm, or detached retina or eye surgery within the past 3 months (spirometry is contraindicated)
Individuals who are in the third trimester of pregnancy
Individuals involved in another interventional trial
